LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway.
Wang H, Wang L, Luan H, Xiao J, Zhao Z, Yu P, Deng M, Liu Y, Ji S, Ma J, Zhou Y, Zhang J, Meng X, Zhang J, Zhao X, Li C, Li F, Wang D, Wei S, Hui L, Nie S, Jin C, An Z, Zhang N, Wang Y, Zhang CC, Li Z.
Wang H, et al. Among authors: jin c.
J Exp Clin Cancer Res. 2024 Jul 1;43(1):183. doi: 10.1186/s13046-024-03110-y.
J Exp Clin Cancer Res. 2024.
PMID: 38951916
Free PMC article.